Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 1995-03-01 (31 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: TOULOUSE (31000), Haute-Garonne
PHARMACIE JEANNE D'ARC : revenue, balance sheet and financial ratios
PHARMACIE JEANNE D'ARC is a French company
founded 31 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in TOULOUSE (31000),
this company of category PME
shows in 2024 a revenue of 1.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE JEANNE D'ARC (SIREN 400337911)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
1 913 559 €
1 593 873 €
N/C
1 727 595 €
1 594 843 €
1 801 020 €
1 846 286 €
1 959 850 €
N/C
Net income
129 249 €
46 997 €
85 015 €
194 570 €
119 586 €
148 248 €
151 935 €
178 673 €
70 156 €
EBITDA
162 509 €
78 214 €
N/C
282 074 €
177 879 €
228 879 €
238 489 €
237 618 €
N/C
Net margin
6.8%
2.9%
N/C
11.3%
7.5%
8.2%
8.2%
9.1%
N/C
Revenue and income statement
In 2024, PHARMACIE JEANNE D'ARC achieves revenue of 1.9 M€. Activity remains stable over the period (CAGR: -0.3%). Vs 2023, growth of +20% (1.6 M€ -> 1.9 M€). After deducting consumption (1.3 M€), gross margin stands at 587 k€, i.e. a rate of 31%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 163 k€, representing 8.5% of revenue. Positive scissor effect: EBITDA margin improves by +3.6 pts, sign of improved operational efficiency. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 129 k€, i.e. 6.8% of revenue. This profit can be retained or distributed to shareholders.
Revenue (2024)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
1 913 559 €
Gross margin (2024)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
587 200 €
EBITDA (2024)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
162 509 €
EBIT (2024)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
157 151 €
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
129 249 €
EBITDA margin (2024)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
8.5%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 10%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 73%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.6 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 6.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
9.787%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
73.428%
Cash flow / Revenue (2024)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
6.69%
Repayment capacity (2024)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
0.633
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
166.346
102.739
69.474
47.164
36.902
26.062
12.578
0.372
9.787
Financial autonomy
28.758
38.855
47.1
54.992
60.898
66.991
75.61
79.256
73.428
Repayment capacity
None
2.167
1.845
1.716
1.797
0.997
None
0.038
0.633
Cash flow / Revenue
None%
9.942%
10.095%
9.064%
8.546%
12.094%
None%
4.245%
6.69%
Sector positioning
Debt ratio
9.792024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Excellent
In 2024, the debt ratio of PHARMACIE JEANNE D'ARC (9.79) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
73.43%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent
In 2024, the financial autonomy of PHARMACIE JEANNE D'ARC (73.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.63 years2024
2023
2024
Q1: 0.52 years
Med: 3.19 years
Q3: 7.6 years
Good
In 2024, the repayment capacity of PHARMACIE JEANNE D'ARC (0.63) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 227.89. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.9x. Danger: operating income does not cover interest charges, unsustainable situation.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
227.894
Interest coverage (2024)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
150.005
193.753
210.214
237.762
284.605
346.326
346.791
196.489
227.894
Interest coverage
None
1.7
1.472
1.305
1.676
0.986
None
5.011
0.919
Sector positioning
Liquidity ratio
227.892024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Good-10 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE JEANNE D'ARC (227.89) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
0.92x2024
2023
2024
Q1: 0.0x
Med: 2.35x
Q3: 7.73x
Average-30 pts over 2 years
In 2024, the interest coverage of PHARMACIE JEANNE D'ARC (0.9x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 2 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 43 days. Excellent situation: suppliers finance 41 days of the operating cycle (retail model). Inventory turnover is 18 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 61 days of revenue, i.e. 322 k€ to permanently finance.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
321 822 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
2 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
43 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
18 j
WCR in days of revenue (2024)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
61 j
WCR and payment terms evolution PHARMACIE JEANNE D'ARC
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
243 688 €
201 910 €
213 277 €
224 857 €
193 387 €
0 €
85 320 €
321 822 €
Inventory turnover (days)
0
19
20
21
30
24
0
20
18
Customer payment term (days)
0
5
2
2
1
0
0
1
2
Supplier payment term (days)
0
45
43
47
40
47
0
43
43
Positioning of PHARMACIE JEANNE D'ARC in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE JEANNE D'ARC is estimated at
1 478 445 €
(range 1 050 637€ - 2 169 242€).
With an EBITDA of 162 509€, the sector multiple of 9.2x is applied.
The price/revenue ratio is 0.64x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1050k€1478k€2169k€
1 478 445 €Range: 1 050 637€ - 2 169 242€
NAF 5 année 2024
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
162 509 €×9.2x
Estimation1 500 683 €
983 014€ - 2 333 254€
Revenue Multiple30%
1 913 559 €×0.64x
Estimation1 224 073 €
1 026 058€ - 1 542 383€
Net Income Multiple20%
129 249 €×14.0x
Estimation1 804 412 €
1 256 564€ - 2 699 503€
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE JEANNE D'ARC with other companies in the same sector:
Frequently asked questions about PHARMACIE JEANNE D'ARC
What is the revenue of PHARMACIE JEANNE D'ARC ?
The revenue of PHARMACIE JEANNE D'ARC in 2024 is 1.9 M€.
Is PHARMACIE JEANNE D'ARC profitable?
Yes, PHARMACIE JEANNE D'ARC generated a net profit of 129 k€ in 2024.
Where is the headquarters of PHARMACIE JEANNE D'ARC ?
The headquarters of PHARMACIE JEANNE D'ARC is located in TOULOUSE (31000), in the department Haute-Garonne.
Where to find the tax return of PHARMACIE JEANNE D'ARC ?
The tax return of PHARMACIE JEANNE D'ARC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE JEANNE D'ARC operate?
PHARMACIE JEANNE D'ARC operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart